You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ACE2

Showing 1 - 25 of 1,857
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Trial (ACE2 Chewing Gum, Placebo Chewing Gum)

Not yet recruiting
  • SARS-CoV-2
  • ACE2 Chewing Gum
  • Placebo Chewing Gum
  • (no location specified)
Jun 24, 2022

Solid Tumor Trial in Beijing (68Ga-DX600 PET/CT)

Completed
  • Solid Tumor
  • 68Ga-DX600 PET/CT
  • Beijing, Beijing, China
    Ethics Committee of Peking University Cancer Hospital
Jul 18, 2022

The Effect of RAAS Blockers on ACE2 Levels

Completed
  • Renin-Angiotensin System
  • ACE inhibitor ,angiotensin receptor blockers
  • Cairo, Select A State Or Province, Egypt
    Ainshams University
Jun 10, 2022

Association of Circulating ACE2 Levels With COVID-19

Completed
  • COVID-19
  • COVID-19 Respiratory Infection
  • ACE serum levels
  • Amman, Jordan
    The University of Jordan
Jan 24, 2022

Cardiovascular Risk Factor, Covid19 Trial in Amman (300 mg of omega3-FA)

Completed
  • Cardiovascular Risk Factor
  • Covid19
  • 300 mg of omega3-FA
  • Amman, Jordan
    Mahmoud S Abu-Samak
Feb 23, 2022

Healthy Trial in Shanghai (SI-F019)

Completed
  • Healthy
  • Shanghai, Shanghai, China
    Shanghai Public Health Clinical Center Ethics Committee Approval
Dec 11, 2022

COVID-19 Respiratory Infection Trial (PD-1 and ACE2 Knockout T Cells)

Not yet recruiting
  • COVID-19 Respiratory Infection
  • PD-1 and ACE2 Knockout T Cells
  • (no location specified)
Aug 13, 2021

Angiotensin Converting Enzyme, Brain, Gut Dysbiosis in Pulmonary

Active, not recruiting
  • Pulmonary Arterial Hypertension
    • Jacksonville, Florida
    • +1 more
    Jan 10, 2022

    ACE2 Gender Differences in Stroke With COVID-19

    Recruiting
    • Neurologic Manifestations
    • Robotic assisted intervention
    • +2 more
    • Rome, Italy
      Fondazione Don Carlo Gnocchi
    Nov 17, 2021

    Diabetic Retinopathy Trial in Birmingham (Diabetic Patients, Healthy Controls)

    Active, not recruiting
    • Diabetic Retinopathy
    • Diabetic Patients
    • Healthy Controls
    • Birmingham, Alabama
      University of Alabama
    Aug 11, 2022

    COVID-19 Trial (Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2))

    Not yet recruiting
    • COVID-19
    • Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2)
    • (no location specified)
    Jun 5, 2021

    COVID-19, Genetic Predisposition to Disease Trial in Pozuelo de Alarcón (Experimental, Control)

    Completed
    • COVID-19
    • Genetic Predisposition to Disease
    • Experimental
    • Control
    • Pozuelo de Alarcón, Madrid, Spain
      David Varillas Delgado
    Jul 14, 2022

    COVID Trial (Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid)

    Not yet recruiting
    • COVID
    • Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid
    • (no location specified)
    Jun 5, 2021

    Covid19 Trial in Sherbrooke (COVID-19 test, Blood sampling)

    Completed
    • Covid19
    • COVID-19 test
    • Blood sampling
    • Sherbrooke, Quebec, Canada
      Sherbrooke University
    Oct 12, 2021

    Beta-thalassemia Trial in Nanning (Luspatercept, Placebo)

    Recruiting
    • Beta-thalassemia
    • Nanning, China
    • +1 more
    Jan 13, 2023

    Angiotensin-converting Enzyme 2 Expression in Tonsils and

    Withdrawn
    • Adenoidectomy
    • Tonsillectomy
    • Storage of operating waste
    • Créteil, France
    • +8 more
    Jul 5, 2021

    Cirrhosis Trial in Rochester (ACE (AI-Cirrhosis-ECG) 2.0)

    Not yet recruiting
    • Cirrhosis
    • ACE (AI-Cirrhosis-ECG) 2.0
    • Rochester, Minnesota
      Mayo Clinic Minnesota
    Mar 12, 2023

    Different Susceptibility to SARS CoV-2 Infection Among Health

    Completed
    • Health Care Worker Patient Transmission
    • +3 more
    • Susceptibility to infection
    • Madrid, Spain
      Hospital Ramon y Cajal
    Oct 23, 2021

    COVID-19 Trial in Chongqing (NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells)

    Recruiting
    • COVID-19
    • NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells
    • Chongqing, China
      Chongqing Public Health Medical Center
    Nov 16, 2020

    Beta Thalassemia Major, Beta Thalassemia Intermedia Trial in Worldwide (SOTATERCEPT (ACE-011))

    Completed
    • Beta Thalassemia Major
    • Beta Thalassemia Intermedia
    • SOTATERCEPT (ACE-011)
    • Créteil, France
    • +14 more
    Aug 18, 2022

    Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • Hypertension
    • Placebo
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University
    Feb 8, 2022

    MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 16, 2023

    Anemia Trial in Worldwide (biological, drug, other)

    Recruiting
    • Anemia
    • Luspatercept
    • +2 more
    • Halifax, Nova Scotia, Canada
    • +11 more
    Jan 3, 2023

    Charcot-Marie-Tooth Disease Trial in United States (ACE-083, Placebo)

    Terminated
    Has Results
    • Charcot-Marie-Tooth Disease
    • Orange, California
    • +15 more
    Sep 13, 2022

    Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

    Not yet recruiting
    • Diabetic Nephropathy Type 2
    • Empagliflozin 25 MG
    • Enalapril Maleate 20 mg
    • (no location specified)
    May 9, 2022